Current Advance in Targeted Treatment and Immunotherapy for BRAF-mutant Advanced Non-small Cell Lung Cancer
With the development of precision medicine, therapies of targeting driver genes have significantly prolonged survival in advanced non-small cell lung cancer (NSCLC) patients. Among them, BRAF gene mutation is relatively rare, and the traditional regimen follows the treatment plan of NSCLC without dr...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Chinês |
| Udgivet: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2021-10-01
|
| Serier: | Chinese Journal of Lung Cancer |
| Fag: | |
| Online adgang: | http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.29 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|